(Q37950136)

25 August 2017

title

Specific immunotherapy in children: the evidence (English)

1 reference

25 August 2017

1 reference

M La Rosa

1

1 reference

25 August 2017

E Lionetti

2

1 reference

25 August 2017

S Leonardi

3

1 reference

25 August 2017

A Salpietro

4

1 reference

25 August 2017

L Bianchi

5

1 reference

25 August 2017

C Salpietro

6

1 reference

25 August 2017

M Miraglia Del Giudice

7

1 reference

25 August 2017

G Ciprandi

8

1 reference

25 August 2017

G L Marseglia

9

1 reference

25 August 2017

publication date

1 October 2011

1 reference

International Journal of Immunopathology and Pharmacology

25 August 2017

published in

1 reference

25 August 2017

volume

24

1 reference

25 August 2017

issue

4 Suppl

1 reference

25 August 2017

page(s)

69-78

1 reference

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Scientific criteria and the selection of allergenic foods for product labelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Sublingual immunotherapy: a double-blind, placebo-controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or both.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Noninjection routes for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Economic evaluation of sublingual vs subcutaneous allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Regulation of proinflammatory cytokines in seasonal allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-gamma-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Bacillus Calmette-Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

The regulation of allergy and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood mononuclear cells of allergic rhinitis patients after specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Interleukin-10, T regulatory cells and specific allergy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Sublingual immunotherapy: efficacy--methodology and outcome of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Mechanisms of allergen specific immunotherapy--T-cell tolerance and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Allergic rhinitis and its impact on asthma update: allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mites

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Systemic reactions from allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Systemic reactions and fatalities associated with allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Survey of fatalities from skin testing and immunotherapy 1985-1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Food allergy after pediatric organ transplantation with tacrolimus immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Safety of sublingual immunotherapy with a monomeric allergoid in very young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

The safety of sublingual-swallow immunotherapy: an analysis of published studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Allergen immunotherapy: where is it now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Allergic rhinitis and its impact on asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Patient's compliance with allergen immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Safety of sublingual-swallow immunotherapy in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Future forms of immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Role of immunmodulators in allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Single-tree nut immunotherapy attenuates allergic reactions in mice with hypersensitivity to multiple tree nuts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Future therapies for food allergies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Intermittent Inhaled Corticosteroids in Infants with Episodic Wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: A longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F03946320110240S413

10.1177/03946320110240S413

21 January 2018

Identifiers

DOI

0 references

1 reference